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Significant gaps remain on the understanding of the in vivo impact of cortisol deficiency on metabolic pathways during embryonic development. Herein, we present a newly established cortisol deficient zebrafish mutant line in order to investigate into the pathogenic effects of cortisol deficiency in vivo.
fdx1b null-allele zebrafish larvae reveal a failure in their Visual
Background Adaptation (VBA) behaviour
The VBA behavior can be rescued with the synthetic steroid hormone dexamethasone (DEX)
Cortisol deficiency leads to metabolic changes in pathways involved in energy and biomolecule synthesis Nuclear magnetic resonance (NMR) spectroscopy
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The zebrafish model for development and endocrine research • Vertebrate
• Large offspring, small embryos (high-throughput studies, drug screens)
• Transparency of embryos (Life imaging)
• Rapid development
• Easy genetic manipulation (TALENs)
• High conservation of endocrine system to human
• We have generated a mutant fdx1b (equivalent of human FDX1) null-allele zebrafish line
• fdx1b deficient embryos are darker due to a failure in Visual Background Adaptation (VBA) behaviour
• VBA in the fdx1b mutants is rescued after dexamethasone treatment
• pomc expression is significantly increased in fdx1b null-allele larvae
• Cortisol synthesis and signalling are significantly impaired
• fdx1b null-allele larvae have a blunted cortisol response to stress
• Metabolic profiling reveals changes in energy synthesis and biomolecule generation
The fdx1b null-allele zebrafish line is a promising in vivo model to explore the pathophysiologic impact of glucocorticoid deficiency on energy metabolism relevant to early development and potentially adult life.
Cortisol production requires electron transfer mediated by ferredoxin (FDX1, Adx) Cortisol 
